Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability.
作者信息
Focosi Daniele, Moscato Giovanna, Pistello Mauro, Maggi Fabrizio
机构信息
North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Division of Laboratory Analysis, Pisa University Hospital, Pisa, Italy.
出版信息
Transfus Med. 2021 Jun;31(3):221-222. doi: 10.1111/tme.12776. Epub 2021 Apr 25.
Abstract
摘要
相似文献
1
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability.4°C下抗SARS-CoV-2刺突蛋白IgG和IgA抗体的动力学：对恢复期血浆稳定性的影响
Transfus Med. 2021 Jun;31(3):221-222. doi: 10.1111/tme.12776. Epub 2021 Apr 25.
2
Isotyping and quantitation of the humoral immune response to SARS-CoV-2.针对 SARS-CoV-2 的体液免疫反应的分型和定量。
Exp Biol Med (Maywood). 2022 Jun;247(12):1055-1060. doi: 10.1177/15353702221084966. Epub 2022 Apr 2.
3
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.比较 COVID-19 恢复期女性人乳与血清中 SARS-CoV-2 特异性抗体的结合能力。
Breastfeed Med. 2021 May;16(5):393-401. doi: 10.1089/bfm.2020.0381. Epub 2021 Apr 9.
4
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.在严重 COVID-19 期间，针对地方性冠状病毒刺突蛋白的血清 IgG 和分泌型 IgA 的异源免疫反应。
Front Immunol. 2022 Mar 9;13:839367. doi: 10.3389/fimmu.2022.839367. eCollection 2022.
5
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice.了解针对 SARS-CoV-2 的中和抗体及其在临床实践中的意义。
Mil Med Res. 2021 Aug 31;8(1):47. doi: 10.1186/s40779-021-00342-3.
6
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.高通量检测 SARS-CoV-2 刺突蛋白靶向抗体在纵向恢复期血浆样本中的存在。
Transfusion. 2021 May;61(5):1377-1382. doi: 10.1111/trf.16318. Epub 2021 Feb 18.
7
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
8
Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-Ecuador.COVID-19患者1.2至10.0个月康复期血浆样本对SARS-CoV-2的中和活性：在厄瓜多尔基多进行的横向替代体外研究
J Med Virol. 2022 Sep;94(9):4246-4252. doi: 10.1002/jmv.27866. Epub 2022 May 26.
9
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.抗严重急性呼吸综合征冠状病毒 2 超免疫球蛋白通过 N 和 S 蛋白显示出强大的中和作用以及抗体依赖的细胞细胞毒性和吞噬作用。
J Infect Dis. 2022 Mar 15;225(6):938-946. doi: 10.1093/infdis/jiab540.
10
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.针对地方性冠状病毒的抗体反应调节 COVID-19 恢复期血浆的功能。
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI146927.
引用本文的文献
1
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review.恢复期血浆在 COVID-19 中的作用：大流行后的结论性综述。
Life (Basel). 2023 Dec 11;13(12):2322. doi: 10.3390/life13122322.
2
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe.欧洲使用新冠康复期血浆进行居家及院外治疗
Life (Basel). 2022 Oct 26;12(11):1704. doi: 10.3390/life12111704.
3
Urgent Need to Regulate Convalescent Plasma Differently from Thawed Plasma.迫切需要对恢复期血浆与解冻血浆进行不同的管理。
Transfus Med Hemother. 2021 Mar;48(2):132-133. doi: 10.1159/000513035. Epub 2020 Dec 21.
本文引用的文献
1
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels.恢复期血浆疗法治疗 COVID-19 患者：抗体检测方法评估及其与中和抗体水平的相关性。
Transfus Med. 2021 Jun;31(3):167-175. doi: 10.1111/tme.12746. Epub 2020 Dec 17.
2
Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks.抗SARS-CoV-2刺突抗体在康复期血浆中于4摄氏度储存至少6周时是稳定的。
Transfusion. 2020 Oct;60(10):2457-2459. doi: 10.1111/trf.16047. Epub 2020 Sep 23.
3
Preanalytical Stability of Antibodies to Pathogenic Antigens.针对病原性抗原的抗体的分析前稳定性。
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1337-1344. doi: 10.1158/1055-9965.EPI-17-0170. Epub 2017 May 8.
4
Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components.血液成分长期储存期间血浆中巨细胞病毒抗体的稳定性。
Clin Diagn Lab Immunol. 1995 Jan;2(1):25-9. doi: 10.1128/cdli.2.1.25-29.1995.
5
Detection of cytomegalovirus antibody in stored blood products using latex agglutination.采用乳胶凝集法检测储存血液制品中的巨细胞病毒抗体。
Transfusion. 1988 Nov-Dec;28(6):563-5. doi: 10.1046/j.1537-2995.1988.28689059032.x.
Zotero 插件